Switch to
More onapp

Tatva Chintan Pharma Chem Ltd

TATVA
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹4,995 cr, stock is ranked 525
Low RiskStock is 1.80x as volatile as Nifty
2,245.608.20 (-0.36%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹4,995 cr, stock is ranked 525
Low RiskStock is 1.80x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
52.11
PB RatioPB Ratio
10.56
Dividend YieldDiv. Yield
0.09%
Sector PESector PE
14.07
Sector PBSector PB
2.74
Sector Div YldSctr Div Yld
2.22%

Forecast & RatingsDetailed Forecast 

80%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Tatva Chintan Pharma Chem is engaged in the manufacturing business of chemical products.

Investor PresentationView older 

Nov 4, 2022

PDF
View Older Presentations

Financial TrendFinancial statements 

2019202020212022207.55264.62305.56442.5420.5437.7852.2795.87
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Schedule of Analysts/Institutional Investor Meet/Con. Call 
Announced OnNov 24, 2022

Tatva Chintan Pharma Chem Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call | Download

Tatva Chintan Pharma Chem Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call | Download

Related Party Transaction 
Announced OnNov 16, 2022

Tatva Chintan Pharma Chem Limited has informed the Exchange about related party transaction for the period ended September 2022 | Download

Tatva Chintan Pharma Chem Limited has informed the Exchange about related party transaction for the period ended September 2022 | Download

Cash Dividend 
Ex. DateSep 8, 2022

Final • Div/Share: ₹ 2

See all events